KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Retained Earnings (2016 - 2025)

Thermo Fisher Scientific's Retained Earnings history spans 17 years, with the latest figure at $59.2 billion for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 11.4% year-over-year to $59.2 billion, compared with a TTM value of $59.2 billion through Dec 2025, up 11.4%, and an annual FY2025 reading of $59.2 billion, up 11.4% over the prior year.
  • Retained Earnings for Q4 2025 was $59.2 billion at Thermo Fisher Scientific, up from $57.4 billion in the prior quarter.
  • The five-year high for Retained Earnings was $59.2 billion in Q4 2025, with the low at -$3.0 billion in Q3 2023.
  • Average Retained Earnings over 5 years is $26.4 billion, with a median of $33.0 billion recorded in 2021.
  • Year-over-year, Retained Earnings crashed 108.64% in 2022 and then soared 2415.46% in 2025.
  • Tracing TMO's Retained Earnings over 5 years: stood at -$2.3 billion in 2021, then soared by 1899.48% to $41.9 billion in 2022, then increased by 13.01% to $47.4 billion in 2023, then increased by 12.11% to $53.1 billion in 2024, then grew by 11.4% to $59.2 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Retained Earnings are $59.2 billion (Q4 2025), $57.4 billion (Q3 2025), and $55.9 billion (Q2 2025).